drugset / Trial / NCT00537563

AMS VS MOXI Ketek vs Avelox in AMS

NCT00537563

Phase 3 Completed 351 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical efficacy between telithromycin and moxifloxacin at the post-therapy/test of cure visit, and to assess the safety of telithromycin given once daily for 5 days vs moxifloxacin given once daily for 10 days in the treatment of subjects with AMS.

Timeline

Start
2002-12
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Telithromycin Small molecule

Indications